Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Cepin – page 4

88 clinical trials in Cepin, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Cepin at a glance
88
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

88 trials in Cepin

Open in trial search

Colitis ulcerative+1

Not recruiting

A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Balinatunfib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Sjogren's syndrome

Not recruiting

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Sjogren's syndrome

Not recruiting

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Sjogren's syndrome

Not recruiting

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting

Study of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks

Registered drug
Countries:CroatiaCroatia
  • Participants:0–17 years
  • Sponsor:Amgen Inc.

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Balinatunfib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Psoriatic arthropathy

Not recruiting

Study of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Psoriatic arthropathy

Not recruiting

Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Alvotech Swiss AG

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Crohn's disease

Not recruiting

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Etrasimod Arginine
  • Sponsor:Arena Pharmaceuticals Inc.

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Cepin

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in Cepin is focused entirely on cardiovascular diseases, with studies exploring new ways to reduce heart-related events and improve long-term outcomes for people living with complex heart conditions.

  • Chronic heart failure
  • Heart failure with mildly reduced or preserved ejection fraction
  • Heart failure with reduced ejection fraction
  • Heart condition

These trials are mainly testing whether newer treatments can better control inflammation, protect the heart, and lower the risk of hospitalization or cardiovascular death.

02 Heart Failure and Inflammation

Several studies are examining heart failure together with systemic inflammation, aiming to see whether targeted therapy can improve outcomes for patients with HFmrEF and HFpEF.

  • HFmrEF
  • HFpEF
  • Systemic inflammation
  • Cardiovascular death and heart failure events

This research is designed to evaluate a potential new treatment approach for people whose heart failure is linked with inflammatory activity.

03 Heart Failure Treatment Options

Another important area of research is the management of heart failure in patients who cannot use standard mineralocorticoid receptor antagonists, with studies looking at both effectiveness and safety.

  • HFrEF
  • Finerenone
  • Safety and tolerability
  • Standard heart failure care

These trials are intended to expand treatment options for people with limited access to current therapies.

04 Diabetes, Hypertension, and Cardiovascular Risk

Research in the city also includes patients with type 2 diabetes, hypertension, and established cardiovascular disease, reflecting the close link between metabolic and heart health.

  • Type 2 diabetes
  • High blood pressure
  • Established cardiovascular disease
  • Heart-related hospital visits

These studies are focused on whether combining therapies can better prevent serious cardiovascular events in high-risk patients.

05 Iron Deficiency in Chronic Heart Failure

One trial is exploring whether treating iron deficiency in people with symptomatic chronic heart failure can improve survival and reduce worsening heart failure.

  • Symptomatic chronic heart failure
  • Iron deficiency
  • Ferric derisomaltose
  • Hospitalization prevention

This line of research aims to clarify the role of iron replacement as part of comprehensive heart failure care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.